Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Date publication

novembre 2018

Journal

The Lancet. Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROY Catherine

Tous les auteurs :
Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30470502

Résumé

Whether multiparametric MRI improves the detection of clinically significant prostate cancer and avoids the need for systematic biopsy in biopsy-naive patients remains controversial. We aimed to investigate whether using this approach before biopsy would improve detection of clinically significant prostate cancer in biopsy-naive patients.

Référence

Lancet Oncol.. 2018 Nov 20;: